Breaking News Instant updates and real-time market news.

ATVI

Activision Blizzard

$41.68

1.57 (3.91%)

08:54
02/13/19
02/13
08:54
02/13/19
08:54

Activision Blizzard price target lowered to $57 from $64 at KeyBanc

KeyBanc analyst Evan Wingren lowered his price target for Activision Blizzard to $57 from $64 following mixed results, and FY19 guidance below the sell-side consensus. However, given the negative reaction in stock year-to-date, the analyst believes this was anticipated. Wingren views the plan to increase development resources by 20% as positive, and believes a return to growth in revenue and EPS in FY20 is likely given a building pipeline and inflecting new business initiatives. He reiterates an Overweight rating on the shares.

  • 14

    Feb

ATVI Activision Blizzard
$41.68

1.57 (3.91%)

02/13/19
JEFF
02/13/19
NO CHANGE
Target $75
JEFF
Buy
Activision Blizzard guidance enough given low expectations, says Jefferies
Reflecting the fact that Blizzard does not have a major front-line release in 2019, Activision Blizzard's 2019 earnings per share outlook of $2.10 is below Street at $2.50 but will be seen as enough to satisfy investors given very low expectations, Jefferies analyst Timothy O'Shea tells investors in a post-earnings research note. The analyst views current valuation levels as an attractive entry point and sees 2020 as the likely "payoff" from the transition year in 2019. He keeps a Buy rating on Activision Blizzard with a $75 price target.
02/13/19
SPHN
02/13/19
NO CHANGE
Target $57
SPHN
Overweight
Activision Blizzard transition year creates buying opportunity, says Stephens
Stephens analyst Jeff Cohen noted that Activision Blizzard (ATVI), like peers Electronic Arts (EA) and Take-Two (TTWO), gave 2019 guidance that was significantly below consensus and framed it as a transition year. Cohen, who said he feels confident now is the time to be buying as 2019 should represent the trough of earnings power, lowered his price target on the shares to $57 from $65 but keeps an Overweight rating on Activision Blizzard shares.
02/13/19
MSCO
02/13/19
NO CHANGE
Target $55
MSCO
Overweight
Morgan Stanley says Activision Blizzard refocusing 'difficult,' but 'necessary'
Morgan Stanley analyst Brian Nowak said Activision Blizzard is taking "difficult, necessary and smart" steps to refocus, stating that he would rather see the company invest behind its strength to create more content, engagement, and monetization opportunities given his view that "there are no "B" gaming titles, only As and Ds." It is now time to execute and timing and performance uncertainty will likely limit the stock's outperformance until the company can deliver another hit game, added Nowak, who lowered his price target on Activision Blizzard shares to $55 from $60 and keeps an Overweight rating.
02/13/19
WEDB
02/13/19
NO CHANGE
Target $56
WEDB
Outperform
Activision Blizzard price target lowered to $56 from $64 at Wedbush
Wedbush analyst Michael Pachter lowered his price target for Activision Blizzard to $56 from $64 after the company's Q4 revenue fell below guidance and estimates driven by softer-than-anticipated Call of Duty sales and in-game monetization for Blizzard titles. Nonetheless, the analyst believes Activision Blizzard could deliver outsized earnings growth by scaling King's ad business, accelerating mobile releases, and making certain titles free-to-play. He reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

SJM

J.M. Smucker

$106.08

2.06 (1.98%)

10:52
02/20/19
02/20
10:52
02/20/19
10:52
Hot Stocks
J.M. Smucker sees FY20 outlook helped by pet prices, hurt by peanut butter price »

In slides for its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 26

    Feb

ETM

Entercom

$7.73

0.22 (2.93%)

10:50
02/20/19
02/20
10:50
02/20/19
10:50
Options
Pre-earnings call buying in Entercom Communications »

Pre-earnings call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

SJM

J.M. Smucker

$106.00

1.98 (1.90%)

10:48
02/20/19
02/20
10:48
02/20/19
10:48
Earnings
J.M. Smucker repeats FY19 adjusted EPS view of $8.00-$8.20, consensus $8.01 »

In slides for its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 26

    Feb

TGEN

Tecogen

$3.84

(0.00%)

10:48
02/20/19
02/20
10:48
02/20/19
10:48
Hot Stocks
Tecogen secures $8.4M trigeneration project in Manhattan »

Tecogen announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKC

Turkcell

$6.97

0.06 (0.87%)

10:47
02/20/19
02/20
10:47
02/20/19
10:47
Hot Stocks
Breaking Hot Stocks news story on Turkcell »

Turkcell trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 14

    Mar

  • 19

    Mar

HON

Honeywell

$153.66

0.39 (0.25%)

10:43
02/20/19
02/20
10:43
02/20/19
10:43
Hot Stocks
Breaking Hot Stocks news story on Honeywell »

Honeywell says UOP will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 29

    Apr

HON

Honeywell

$153.66

0.39 (0.25%)

10:41
02/20/19
02/20
10:41
02/20/19
10:41
Hot Stocks
Honeywell says UOP has been 'very disciplined' on the cost side »

Says Honeywell UOP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 29

    Apr

FITB

Fifth Third

$27.49

-0.025 (-0.09%)

10:40
02/20/19
02/20
10:40
02/20/19
10:40
Options
Bearish option flow in Fifth Third Bancorp »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 12

    Mar

10:40
02/20/19
02/20
10:40
02/20/19
10:40
General news
Money market rates have dipped »

Money market rates have…

10:35
02/20/19
02/20
10:35
02/20/19
10:35
Conference/Events
Morgan Stanley sports/footwear analyst to hold analyst/industry conference call »

Sports & Footwear…

KO

Coca-Cola

$44.99

0.17 (0.38%)

10:30
02/20/19
02/20
10:30
02/20/19
10:30
Options
Vote of confidence in Coca Cola »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

ARW

Arrow Electronics

$81.74

0.73 (0.90%)

10:28
02/20/19
02/20
10:28
02/20/19
10:28
Hot Stocks
Arrow Electronics CEO sells over $4.3M worth of shares »

Arrow Electronics CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

10:25
02/20/19
02/20
10:25
02/20/19
10:25
Conference/Events
Credit Suisse analysts to hold an analyst/industry conference call »

Analysts discuss the HOLT…

10:25
02/20/19
02/20
10:25
02/20/19
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

FLR

Fluor

$37.46

0.46 (1.24%)

, HAL

Halliburton

$32.29

0.59 (1.86%)

10:21
02/20/19
02/20
10:21
02/20/19
10:21
Hot Stocks
Fluor awarded Halliburton chemicals project in Saudi Arabia »

Fluor (FLR) announced…

FLR

Fluor

$37.46

0.46 (1.24%)

HAL

Halliburton

$32.29

0.59 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 15

    May

  • 22

    May

  • 28

    May

W

Wayfair

$120.90

0.67 (0.56%)

10:20
02/20/19
02/20
10:20
02/20/19
10:20
Hot Stocks
Hedgeye names Wayfair as new short idea »

Hedgeye named Wayfair as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

TSLA

Tesla

$304.20

-1.36 (-0.45%)

10:20
02/20/19
02/20
10:20
02/20/19
10:20
Options
Put buyers in Tesla weekly options »

Put buyers in Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

IRM

Iron Mountain

$35.51

0.12 (0.34%)

10:18
02/20/19
02/20
10:18
02/20/19
10:18
Recommendations
Iron Mountain analyst commentary  »

Iron Mountain price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
02/20/19
02/20
10:17
02/20/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$306.68

1.33 (0.44%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Hot Stocks
Humana, PatientPing announce agreement to improve care coordination »

PatientPing announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 19

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOD

Kodiak Sciences

$7.51

0.64 (9.32%)

, VEEV

Veeva

$120.49

0.1 (0.08%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

KOD

Kodiak Sciences

$7.51

0.64 (9.32%)

VEEV

Veeva

$120.49

0.1 (0.08%)

AGIO

Agios Pharmaceuticals

$58.78

1.07 (1.85%)

KIDS

OrthoPediatrics

$38.69

1.31 (3.50%)

FIXX

Homology Medicines

$24.90

0.87 (3.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 13

    Mar

  • 26

    Mar

  • 27

    Mar

  • 10

    Apr

  • 11

    Apr

  • 21

    Jun

CVS

CVS Health

$63.82

-6.1 (-8.72%)

, LUV

Southwest

$54.63

-3.03 (-5.25%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CVS

CVS Health

$63.82

-6.1 (-8.72%)

LUV

Southwest

$54.63

-3.03 (-5.25%)

SCHW

Charles Schwab

$45.95

-1.11 (-2.36%)

ETFC

E-Trade

$48.05

-0.61 (-1.25%)

PANW

Palo Alto Networks

$228.77

-1.42 (-0.62%)

TEVA

Teva

$17.40

-0.61 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 04

    Mar

  • 05

    Mar

  • 12

    Mar

IPSEY

Ipsen

$0.00

(0.00%)

, CS

Credit Suisse

$11.91

0.005 (0.04%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

IPSEY

Ipsen

$0.00

(0.00%)

CS

Credit Suisse

$11.91

0.005 (0.04%)

AXL

American Axle

$16.92

0.32 (1.93%)

DO

Diamond Offshore

$10.65

0.36 (3.50%)

RIG

Transocean

$8.86

0.12 (1.37%)

PFE

Pfizer

$42.25

-0.33 (-0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    May

  • 22

    May

LUV

Southwest

$54.67

-2.99 (-5.19%)

, ALK

Alaska Air

$63.60

-0.95 (-1.47%)

10:15
02/20/19
02/20
10:15
02/20/19
10:15
On The Fly
Goldman Sachs says sell Southwest as airline cuts guidance »

Shares of Southwest (LUV)…

LUV

Southwest

$54.67

-2.99 (-5.19%)

ALK

Alaska Air

$63.60

-0.95 (-1.47%)

AAL

American Airlines

$34.96

-0.5 (-1.41%)

UAL

United Continental

$87.68

-1.53 (-1.72%)

DAL

Delta Air Lines

$50.89

-0.93 (-1.79%)

JBLU

JetBlue

$17.68

-0.24 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 04

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.